Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Kimberly-Clark manufactures and markets essential personal care products (Huggies diapers, Kleenex tissues, Cottonelle toilet paper, Kotex feminine care) across 175 countries, with ~50% revenue from North America and significant exposure to emerging markets. The company operates a capital-intensive pulp and paper manufacturing base with 85 facilities globally, competing primarily on brand equity and distribution scale against P&G, Unilever, and private label. Stock performance is driven by pricing power versus input cost inflation (pulp, polymer resins, energy), volume trends in developed markets, and emerging market currency/demand dynamics.
KMB generates revenue through branded consumer staples sold via retail channels (Walmart, Target, grocery) and professional distribution networks. Pricing power derives from 140+ year brand heritage and category leadership positions (Huggies #1 in North America diapers, Kleenex synonymous with facial tissue). Gross margins of 35.6% reflect vertically integrated pulp manufacturing (10 pulp mills providing ~30% of fiber needs) which hedges input costs but creates fixed cost base. Operating leverage is moderate - benefits from scale in advertising/distribution but constrained by commodity exposure and promotional spending to defend shelf space against private label. The company targets 3-5% organic sales growth through innovation (premium tier products), geographic expansion, and price increases to offset $1.5-2.0B annual commodity/freight inflation.
Pulp and polymer resin cost trends - Northern Bleached Softwood Kraft (NBSK) pulp pricing directly impacts 25-30% of COGS, with $50/ton move equating to ~$100M annual EBIT impact
Organic sales growth decomposition - volume/mix versus price realization, particularly in North America Personal Care (40% of profit pool)
Emerging market currency headwinds - 30% of revenue from Latin America, Eastern Europe, Asia where FX translation creates 200-400bps revenue drag in strong dollar environments
Private label share shifts in tissue category - discount retailers expanding store brands pressuring volume and forcing promotional spending
Diaper category birth rate trends and market share in North America - secular decline of 1-2% annually in developed market births offset by premiumization and adult incontinence growth
Secular birth rate decline in developed markets - North America/Europe births down 1-2% annually, pressuring core diaper franchise representing 25-30% of company revenue
Private label penetration in tissue category - store brands now 30% of U.S. toilet paper market versus 18% a decade ago, forcing increased promotional spending and eroding pricing power
E-commerce disruption of traditional retail distribution - Amazon private label (Mama Bear diapers, Presto tissue) and direct-to-consumer brands (Honest Company, Hello Bello) bypassing KMB's retail shelf space advantage
ESG and plastic packaging regulations - increasing pressure to eliminate plastic components in diapers/wipes and shift to sustainable forestry, requiring $500M+ capex investment
Procter & Gamble's Pampers brand maintains 40% North America diaper share versus Huggies 25%, with superior innovation pipeline and marketing spend creating sustained share loss risk
Unilever and private equity-backed brands (Essity) gaining tissue share through aggressive pricing and retailer partnerships
Vertical integration by retailers - Costco's Kirkland Signature tissue manufactured by third parties at lower cost structure threatens premium branded positioning
Elevated leverage at 4.77x Debt/Equity with $7.8B gross debt limits financial flexibility for M&A or aggressive share buybacks - net debt/EBITDA ~3.0x
Pension and OPEB obligations of $1.2B underfunded status creates potential cash funding requirements if discount rates decline further
Current ratio of 0.75x indicates working capital deficit, though typical for consumer staples with negative cash conversion cycles - reliant on commercial paper markets for liquidity
low - Personal care and tissue products are non-discretionary staples with inelastic demand through economic cycles. However, consumer trading down to private label during recessions pressures volumes and margins. K-C Professional segment (20% of sales) has moderate cyclicality tied to commercial real estate occupancy and industrial activity. Birth rates show weak correlation to GDP but stronger link to consumer confidence and housing formation with 12-18 month lag.
Moderate sensitivity through two channels: (1) $7.8B debt load (4.77x D/E) creates refinancing risk as rates rise - weighted average cost of debt ~3.5% with $1.2B maturing through 2025; (2) Higher rates compress valuation multiples for dividend-oriented consumer staples, particularly given 24.3x P/B premium valuation; (3) Mortgage rates indirectly impact diaper demand through household formation and birth rates with 18-24 month lag. Rising rates are net negative for stock performance despite minimal direct earnings impact.
Minimal - B2B sales through K-C Professional segment represent 20% of revenue but customers are diversified distributors and facility management companies. Consumer products sold primarily through investment-grade retailers (Walmart, Costco, Kroger). Working capital benefits from negative cash conversion cycle (payables exceed receivables). Credit conditions matter indirectly through consumer access to financing for big-ticket purchases that correlate with household formation.
dividend/value - 4.1% dividend yield and 85-year consecutive payout history attracts income-focused investors and defensive allocators. Negative revenue growth (-14.2% YoY) and margin pressure from input cost inflation has shifted sentiment from quality compounder to value/turnaround opportunity. High 155% ROE (inflated by negative equity from share buybacks) and stable FCF generation appeal to yield-focused strategies. Recent 19% drawdown creates entry point for contrarian value investors betting on margin recovery as commodity costs normalize.
low - Beta typically 0.5-0.6 given non-discretionary product portfolio and stable cash flows. Recent 19% decline over 12 months reflects commodity cost squeeze and competitive pressures rather than fundamental demand destruction. Daily volatility historically 12-15% annualized, well below S&P 500, making it core holding for low-volatility and minimum-variance strategies.
